PNAd activators encompass a range of compounds that can influence the adhesion of lymphocytes to endothelial cells in peripheral lymph nodes. These compounds act through various mechanisms that indirectly enhance the functional activity of PNAd. For instance, retinoic acid and vitamin D3 are known to regulate immune cell function and the expression of adhesion molecules. An increase in the expression of integrins and other adhesion molecules could result in a stronger interaction with PNAd, thereby enhancing lymphocyte homing to peripheral lymph nodes. Similarly, L-selectin, a ligand for PNAd, when increased in the system, could enhance the adhesion strength between lymphocytes and PNAd.
Compounds like sphingosine-1-phosphate and galectin-1 have roles in the signaling pathways related to lymphocyte trafficking and adhesion. Sphingosine-1-phosphate regulates lymphocyte egress from lymph nodes, which indirectly affects the recirculation and, the PNAd-mediated adhesion process. Galectin-1 binds to carbohydrate structures on PNAd and can modulate the adhesion of lymphocytes, thereby influencing PNAd functionality. IL-4, a cytokine, can upregulate the expression of vascular cell adhesion molecule-1 (VCAM-1) which can work in concert with PNAd to enhance lymphocyte adhesion and trafficking.
Items 171 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|